Cyberbiosecurity

Last updated

Cyberbiosecurity is an emerging field at the intersection of cybersecurity and biosecurity. [1] [2] [3] The objective of cyberbiosecurity has been described as addressing "the potential for or actual malicious destruction, misuse, or exploitation of valuable information, processes, and material at the interface of the life sciences and digital worlds". [2] Cyberbiosecurity is part of a system of measures that collectively aim to "Safeguard the Bioeconomy", an objective described by the National Academies of Sciences, Engineering and Medicine of the United States. [4] [5]

Cyberbiosecurity threats

Cyberbiosecurity threats are becoming increasingly important as technological progress continues to accelerate in fields such as artificial intelligence, automation, and synthetic biology. [2] [6] Moreover, not only is the pace of progress in these fields accelerating, but they are also becoming increasingly integrated, leading to a growing overlap that is generating new security vulnerabilities. [4] [7] Many of the potential risks from future progress in bioengineering that were identified by researchers fall within the bounds of cyberbiosecurity, for instance, the use of cyberattacks to exploit bio-automation for malicious purposes. [8] Against this background, cyberbiosecurity measures are becoming increasingly important to prevent or protect against the misuse of innovations in the life sciences, including to reduce the proliferation risk of biological weapons. In recent years, there has been a growing amount of research characterizing cyberbiosecurity threats, including by conducting surveys on cyberbiosecurity risk perceptions in the biotech sector, [9] and offering first recommendations for measures to prevent or protect against these threats. [10] [11] [12] [13] Researchers have observed that in the future it may be critical to consider the risk of computer systems being exploited by adversarially created DNA. [14] [15]

In light of the COVID-19 pandemic, some research has focused on the cyberbiosecurity implications of the pandemic. [16]

Related Research Articles

Primary nutritional groups are groups of organisms, divided in relation to the nutrition mode according to the sources of energy and carbon, needed for living, growth and reproduction. The sources of energy can be light or chemical compounds; the sources of carbon can be of organic or inorganic origin.

<span class="mw-page-title-main">Synthetic biology</span> Interdisciplinary branch of biology and engineering

Synthetic biology (SynBio) is a multidisciplinary field of science that focuses on living systems and organisms, and it applies engineering principles to develop new biological parts, devices, and systems or to redesign existing systems found in nature.

Alpha hydroxy acids, or α-hydroxy acids, are a class of chemical compounds that consist of a carboxylic acid with a hydroxyl group substituent on the adjacent (alpha) carbon. Prominent examples are glycolic acid, lactic acid, mandelic acid and citric acid.

Magnetofection is a transfection method that uses magnetic fields to concentrate particles containing vectors to target cells in the body. Magnetofection has been adapted to a variety of vectors, including nucleic acids, non-viral transfection systems, and viruses. This method offers advantages such as high transfection efficiency and biocompatibility which are balanced with limitations.

<span class="mw-page-title-main">GLUT5</span> Protein-coding gene in the species Homo sapiens

GLUT5 is a fructose transporter expressed on the apical border of enterocytes in the small intestine. GLUT5 allows for fructose to be transported from the intestinal lumen into the enterocyte by facilitated diffusion due to fructose's high concentration in the intestinal lumen. GLUT5 is also expressed in skeletal muscle, testis, kidney, fat tissue (adipocytes), and brain.

<span class="mw-page-title-main">Methanol dehydrogenase</span>

In enzymology, a methanol dehydrogenase (MDH) is an enzyme that catalyzes the chemical reaction:

Cell-free protein synthesis, also known as in vitro protein synthesis or CFPS, is the production of protein using biological machinery in a cell-free system, that is, without the use of living cells. The in vitro protein synthesis environment is not constrained by a cell wall or homeostasis conditions necessary to maintain cell viability. Thus, CFPS enables direct access and control of the translation environment which is advantageous for a number of applications including co-translational solubilisation of membrane proteins, optimisation of protein production, incorporation of non-natural amino acids, selective and site-specific labelling. Due to the open nature of the system, different expression conditions such as pH, redox potentials, temperatures, and chaperones can be screened. Since there is no need to maintain cell viability, toxic proteins can be produced.

Casamino acid is the mixture of amino acids produced from acid hydrolysis of casein, a family of phosphoproteins found in mammalian milk. In comparison, tryptone describes casein that has undergone enzymatic degradation by the protease trypsin, leaving many smaller peptide chains alongside the free amino acids.

<span class="mw-page-title-main">Fracture blister</span> Medical condition in skin overlying a fractured bone

Fracture blisters occur on skin overlying a fractured bone, and fractures complicated by the development of overlying blisters remain a clinical dilemma in orthopedics.

<span class="mw-page-title-main">Phonocardiogram</span>

A phonocardiogram is a plot of high-fidelity recording of the sounds and murmurs made by the heart with the help of the machine called the phonocardiograph; thus, phonocardiography is the recording of all the sounds made by the heart during a cardiac cycle.

<span class="mw-page-title-main">Viral metagenomics</span>

Viral metagenomics uses metagenomic technologies to detect viral genomic material from diverse environmental and clinical samples. Viruses are the most abundant biological entity and are extremely diverse; however, only a small fraction of viruses have been sequenced and only an even smaller fraction have been isolated and cultured. Sequencing viruses can be challenging because viruses lack a universally conserved marker gene so gene-based approaches are limited. Metagenomics can be used to study and analyze unculturable viruses and has been an important tool in understanding viral diversity and abundance and in the discovery of novel viruses. For example, metagenomics methods have been used to describe viruses associated with cancerous tumors and in terrestrial ecosystems.

Biotechnology risk is a form of existential risk from biological sources, such as genetically engineered biological agents. The release of such high-consequence pathogens could be

<span class="mw-page-title-main">Microbial cell factory</span>

Microbial cell factory is an approach to bioengineering which considers microbial cells as a production facility in which the optimization process largely depends on metabolic engineering. MCFs is a derivation of cell factories, which are engineered microbes and plant cells. In 1980s and 1990s, MCFs were originally conceived to improve productivity of cellular systems and metabolite yields through strain engineering. A MCF develops native and nonnative metabolites through targeted strain design. In addition, MCFs can shorten the synthesis cycle while reducing the difficulty of product separation.

Hydrogels are three-dimensional networks consisting of chemically or physically cross-linked hydrophilic polymers. The insoluble hydrophilic structures absorb polar wound exudates and allow oxygen diffusion at the wound bed to accelerate healing. Hydrogel dressings can be designed to prevent bacterial infection, retain moisture, promote optimum adhesion to tissues, and satisfy the basic requirements of biocompatibility. Hydrogel dressings can also be designed to respond to changes in the microenvironment at the wound bed. Hydrogel dressings should promote an appropriate microenvironment for angiogenesis, recruitment of fibroblasts, and cellular proliferation.

<span class="mw-page-title-main">PETase</span> Class of enzymes

PETases are an esterase class of enzymes that catalyze the breakdown (via hydrolysis) of polyethylene terephthalate (PET) plastic to monomeric mono-2-hydroxyethyl terephthalate (MHET). The idealized chemical reaction is:

Trench nephritis, also known as war nephritis, is a kidney infection, first recognised by medical officers as a new disease during the early part of the First World War and distinguished from the then-understood acute nephritis by also having bronchitis and frequent relapses. Trench nephritis was the major kidney problem of the war. The cause was not established at the time, treatments were ineffective, and the condition led to 35,000 British and 2,000 American casualties.

A laboratory-acquired infection or LAI is an infection that is acquired in a laboratory, usually as part of a medical research facility or hospital.

Mark J. Shelhamer is an American human spaceflight researcher specializing in neurovestibular adaptation to space flight., and former chief scientist of NASA's Human Research Program. He is a Professor of Otolaryngology - Head and Neck Surgery at the Johns Hopkins School of Medicine, director of the Human Spaceflight Lab at Johns Hopkins, and director and founder of the Bioastronautics@Hopkins initiative. He is also an adjunct associate professor at George Washington University School of Medicine and Health Sciences. He has published over 70 scientific papers and is the author of Nonlinear Dynamics in Physiology: A State-Space Approach. He holds several patents for various vestibular assessment devices.

A cloud laboratory is a heavily automated, centralized research laboratory where scientists can run an experiment from a computer in a remote location. Cloud laboratories offer the execution of life science research experiments as a service, allowing researchers to retain full control over experimental design. Users create experimental protocols through a high-level API and the experiment is executed in the cloud laboratory, with no need for the user to be involved.

<span class="mw-page-title-main">Liposome extruder</span> Lab equipment

A liposome extruder is a device that prepares cell membranes, exosomes and also generates nanoscale liposome formulations. The liposome extruder employs the track-etched membrane to filter huge particles and achieve sterile filtration.

References

  1. Peccoud, Jean; Gallegos, Jenna E.; Murch, Randall; Buchholz, Wallace G.; Raman, Sanjay (2018). "Cyberbiosecurity: From Naive Trust to Risk Awareness". Trends in Biotechnology. 36 (1): 4–7. doi:10.1016/j.tibtech.2017.10.012. ISSN   1879-3096. PMID   29224719.
  2. 1 2 3 Richardson, Lauren C.; Connell, Nancy D.; Lewis, Stephen M.; Pauwels, Eleonore; Murch, Randy S. (2019-06-06). "Cyberbiosecurity: A Call for Cooperation in a New Threat Landscape". Frontiers in Bioengineering and Biotechnology. 7: 99. doi: 10.3389/fbioe.2019.00099 . ISSN   2296-4185. PMC   6562220 . PMID   31245363.
  3. "Mapping the Cyberbiosecurity Enterprise | Frontiers Research Topic". www.frontiersin.org. Retrieved 2020-11-12.
  4. 1 2 Murch, Randall S.; So, William K.; Buchholz, Wallace G.; Raman, Sanjay; Peccoud, Jean (2018-04-05). "Cyberbiosecurity: An Emerging New Discipline to Help Safeguard the Bioeconomy". Frontiers in Bioengineering and Biotechnology. 6: 39. doi: 10.3389/fbioe.2018.00039 . ISSN   2296-4185. PMC   5895716 . PMID   29675411.
  5. Safeguarding the Bioeconomy. National Academies of Sciences, Engineering, and Medicine. 2020-01-14. doi:10.17226/25525. ISBN   978-0-309-49567-7. PMID   32352690. S2CID   214395865.
  6. George, Asha M. (2019). "The National Security Implications of Cyberbiosecurity". Frontiers in Bioengineering and Biotechnology. 7: 51. doi: 10.3389/fbioe.2019.00051 . ISSN   2296-4185. PMC   6438857 . PMID   30968020.
  7. Schabacker, Daniel S.; Levy, Leslie-Anne; Evans, Nate J.; Fowler, Jennifer M.; Dickey, Ellen A. (2019). "Assessing Cyberbiosecurity Vulnerabilities and Infrastructure Resilience". Frontiers in Bioengineering and Biotechnology. 7: 61. doi: 10.3389/fbioe.2019.00061 . ISSN   2296-4185. PMC   6455068 . PMID   31001526.
  8. Wintle, Bonnie C; Boehm, Christian R; Rhodes, Catherine; Molloy, Jennifer C; Millett, Piers; Adam, Laura; Breitling, Rainer; Carlson, Rob; Casagrande, Rocco; Dando, Malcolm; Doubleday, Robert (2017). "A transatlantic perspective on 20 emerging issues in biological engineering". eLife. 6. doi: 10.7554/eLife.30247 . ISSN   2050-084X. PMC   5685469 . PMID   29132504.
  9. Millett, Kathryn; Dos Santos, Eduardo; Millett, Piers D. (2019). "Cyber-Biosecurity Risk Perceptions in the Biotech Sector". Frontiers in Bioengineering and Biotechnology. 7: 136. doi: 10.3389/fbioe.2019.00136 . ISSN   2296-4185. PMC   6593240 . PMID   31275929.
  10. Reed, J. Craig; Dunaway, Nicolas (2019). "Cyberbiosecurity Implications for the Laboratory of the Future". Frontiers in Bioengineering and Biotechnology. 7: 182. doi: 10.3389/fbioe.2019.00182 . ISSN   2296-4185. PMC   6712584 . PMID   31497596.
  11. Mantle, Jennifer L.; Rammohan, Jayan; Romantseva, Eugenia F.; Welch, Joel T.; Kauffman, Leah R.; McCarthy, Jim; Schiel, John; Baker, Jeffrey C.; Strychalski, Elizabeth A.; Rogers, Kelley C.; Lee, Kelvin H. (2019). "Cyberbiosecurity for Biopharmaceutical Products". Frontiers in Bioengineering and Biotechnology. 7: 116. doi: 10.3389/fbioe.2019.00116 . ISSN   2296-4185. PMC   6554447 . PMID   31214582.
  12. Richardson, Lauren C.; Lewis, Stephen M.; Burnette, Ryan N. (2019). "Building Capacity for Cyberbiosecurity Training". Frontiers in Bioengineering and Biotechnology. 7: 112. doi: 10.3389/fbioe.2019.00112 . ISSN   2296-4185. PMC   6606988 . PMID   31297367.
  13. Walsh, Patrick et al. (2021). Threats, Risks and Vulnerabilities At the Intersection of Digital, Bio and Health.
  14. Greenberg, Andy. "Biohackers Encoded Malware in a Strand of DNA". Wired.
  15. Computer Security, Privacy, and DNA Sequencing: Compromising Computers with Synthesized DNA, Privacy Leaks, and More. USENIX Association. 2017. pp. 765–779. ISBN   9781931971409.
  16. Mueller, Siguna (2020-09-25). "Facing the 2020 Pandemic: What does Cyberbiosecurity want us to know to safeguard the future?". Biosafety and Health. 3 (1): 11–21. doi:10.1016/j.bsheal.2020.09.007. ISSN   2590-0536. PMC   7518802 . PMID   33015604.